Sagespring Wealth Partners LLC Has $297,000 Stock Position in Cardinal Health, Inc. $CAH

Sagespring Wealth Partners LLC increased its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 4.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,768 shares of the company’s stock after acquiring an additional 80 shares during the quarter. Sagespring Wealth Partners LLC’s holdings in Cardinal Health were worth $297,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. grew its position in Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after purchasing an additional 1,193,983 shares during the last quarter. Northern Trust Corp grew its position in Cardinal Health by 3.5% during the first quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock worth $433,012,000 after buying an additional 105,154 shares in the last quarter. Wellington Management Group LLP grew its position in Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after buying an additional 2,249,241 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in Cardinal Health by 3.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company’s stock valued at $227,877,000 after acquiring an additional 52,714 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in Cardinal Health by 0.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company’s stock valued at $171,749,000 after acquiring an additional 7,940 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Jason M. Hollar sold 35,901 shares of the stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the sale, the chief executive officer owned 200,000 shares in the company, valued at approximately $30,008,000. This represents a 15.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the sale, the insider owned 48,457 shares of the company’s stock, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is currently owned by insiders.

Cardinal Health Stock Performance

CAH opened at $156.29 on Friday. The firm has a market cap of $37.13 billion, a price-to-earnings ratio of 24.23, a PEG ratio of 1.30 and a beta of 0.71. The firm’s 50-day simple moving average is $151.88 and its 200-day simple moving average is $151.72. Cardinal Health, Inc. has a twelve month low of $106.98 and a twelve month high of $168.44.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm’s quarterly revenue was up .5% on a year-over-year basis. During the same period last year, the firm posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were given a dividend of $0.5107 per share. The ex-dividend date was Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. Cardinal Health’s dividend payout ratio is 31.63%.

Wall Street Analyst Weigh In

CAH has been the topic of a number of research reports. Robert W. Baird boosted their price objective on Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research report on Wednesday, August 13th. Jefferies Financial Group set a $150.00 price target on shares of Cardinal Health in a report on Tuesday, August 12th. Wall Street Zen cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Evercore ISI cut their price target on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Finally, UBS Group reiterated a “buy” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $166.00.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.